11 results
10-K
2019 FY
REPL
Replimune Group Inc
28 Jun 19
Annual report
5:10pm
providers. Recently, states have enacted or are considering legislation intended to make drug prices more transparent and deter significant price
424B4
gxh ujt65on7etx6i1l5
23 Jul 18
Prospectus supplement with pricing info
4:58pm
S-1/A
oprritzp0dnx
26 Jun 18
IPO registration (amended)
5:24pm
S-1
jf9vxod 3dzurhac
22 Jun 18
IPO registration
5:30pm
DRS/A
ed9ript
11 Jun 18
Draft registration statement (amended)
12:00am
DRS
9b6lr
3 May 18
Draft registration statement
12:00am
- Prev
- 1
- Next